Predicting Food Effects on Drug Release from Extended-Release Oral Dosage Forms Containing a Narrow Therapeutic Index Drug

被引:17
|
作者
Klein, Sandra [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Pharmaceut Technol, D-60438 Frankfurt, Germany
来源
DISSOLUTION TECHNOLOGIES | 2009年 / 16卷 / 03期
关键词
IN-VIVO DISSOLUTION; GASTROINTESTINAL TRANSIT; THEOPHYLLINE ABSORPTION; FORMULATION; VITRO; BIOAVAILABILITY; DELIVERY; MATRICES; SINGLE; TRACT;
D O I
10.14227/DT160309P28
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two schemes were designed to facilitate easy and efficient preparation of biorelevant "pH gradients" representing small intestinal conditions in the fasted and fed states. Results of release tests performed on theophylline MR preparations using these profiles correlated well with in vivo data (3). This indicates that the new schemes can be very useful in terms of performing effective and reliable in vitro tests to predict the in vivo behavior of MR dosage forms.
引用
收藏
页码:28 / 40
页数:13
相关论文
共 50 条
  • [31] COMPARISON OF DISSOLUTION PROFILES OF THEOPHYLLINE EXTENDED-RELEASE DOSAGE FORMS
    Wolny, Dantel
    Gruchlik, Arkadiusz
    Chodurek, Ewa
    Szara, Magdalena
    Dzierzewicz, Zofia
    ACTA POLONIAE PHARMACEUTICA, 2012, 69 (06): : 1384 - 1386
  • [32] Extended-release drug formulations for the treatment of epilepsy
    Brandt, Christian
    May, Theodor W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (08) : 843 - 850
  • [33] Accelerated in-vitro release testing methods for extended-release parenteral dosage forms
    Shen, Jie
    Burgess, Diane J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (07) : 986 - 996
  • [34] THE INVITRO DEVELOPMENT OR ORAL EXTENDED RELEASE DOSAGE FORMS
    LEESON, LJ
    PHARMAZEUTISCHE INDUSTRIE, 1986, 48 (05): : 519 - 521
  • [35] Mathematical modeling of drug release from lipid dosage forms
    Siepmann, J.
    Siepmann, F.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 418 (01) : 42 - 53
  • [36] ON THE DETERMINATION OF DRUG RELEASE RATES FROM TOPICAL DOSAGE FORMS
    GUY, RH
    HADGRAFT, J
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 60 (02) : R1 - R3
  • [37] WORKSHOP-II REPORT - SCALE-UP OF ORAL EXTENDED-RELEASE DOSAGE FORMS
    SKELLY, JP
    VANBUSKIRK, GA
    ARBIT, HM
    AMIDON, GL
    AUGSBURGER, L
    BARR, WH
    BERGE, S
    CLEVENGER, J
    DIGHE, S
    FOX, D
    GONZALEZ, MA
    GRAY, VA
    HOIBERG, C
    JERUSSI, R
    LEESON, LJ
    LESKO, L
    MALINOWSKI, H
    NIXON, PR
    PEARCE, DM
    PECK, G
    PORTER, S
    ROBINSON, J
    SAVELLO, DR
    SCHWARTZ, P
    SCHWARTZ, JB
    SHAH, VP
    THEEUWES, F
    WHEATLEY, T
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1993, 39 (04) : 162 - 167
  • [38] Novel extended-release carbamazepine oral suspension: Formulation, evaluation and drug-release kinetic study
    Alsammarraie, Harith Jameel Mahdi
    Al-Abasi, Menaa Abdulsalam
    Mohammad, Adnan Majeed
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 37 (06) : 1615 - 1624
  • [39] Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets
    Gao, Zongming
    Ngo, Cindy
    Ye, Wei
    Rodriguez, Jason D.
    Keire, David
    Sun, Dajun
    Wen, Hong
    Jiang, Wenlei
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (03) : 1189 - 1194
  • [40] Assessment of drug transfer in tissues with oral dosage forms with controlled release.
    Saidna, M
    Ouriemchi, EM
    Vergnaud, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1236 - U1236